ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer (Q43541762)

24 November 2017

ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer (English)

1 reference

24 November 2017

0 references

1

Ute Warnecke-Eberz

1 reference

24 November 2017

Elfriede Bollschweiler

6

object named as

Elfriede Bollschweiler

1 reference

24 November 2017

10

Ralf Metzger

1 reference

24 November 2017

9

Arnulf H Hölscher

1 reference

24 November 2017

Daniel Vallböhmer

2

1 reference

24 November 2017

Hakan Alakus

3

1 reference

24 November 2017

Fabian Kütting

4

1 reference

24 November 2017

Georg Lurje

5

1 reference

24 November 2017

Anke Wienand-Dorweiler

7

1 reference

24 November 2017

Uta Drebber

8

1 reference

24 November 2017

7 May 2009

1 reference

Journal of Gastrointestinal Surgery

24 November 2017

1 reference

24 November 2017

13

1 reference

24 November 2017

8

1 reference

24 November 2017

1411-1421

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-009-0881-z

24 November 2017

0 references

cites work

Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Locally advanced esophageal cancer

21 January 2018

1 reference

12 December 2020

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

1 reference

12 December 2020

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

12 December 2020

Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array

1 reference

12 December 2020

Polymorphisms in DNA repair genes and associations with cancer risk

1 reference

12 December 2020

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review

1 reference

12 December 2020

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

12 December 2020

Determinants of chemosensitivity in gastric cancer

1 reference

12 December 2020

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery

1 reference

12 December 2020

A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation

1 reference

12 December 2020

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

1 reference

12 December 2020

ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.

1 reference

12 December 2020

Cancer pharmacogenetics: polymorphisms, pathways and beyond

1 reference

12 December 2020

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

12 December 2020

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

12 December 2020

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

1 reference

12 December 2020

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays

1 reference

12 December 2020

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

1 reference

12 December 2020

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

12 December 2020

Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.

1 reference

12 December 2020

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

Genetic polymorphisms and head and neck cancer risk (Review).

1 reference

12 December 2020

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

1 reference

12 December 2020

Human DNA repair genes

1 reference

12 December 2020

Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Survival after surgery for oesophageal cancer: a population-based study.

1 reference

12 December 2020

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

1 reference

12 December 2020

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer

1 reference

12 December 2020

[Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma]

1 reference

12 December 2020

Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.

1 reference

12 December 2020

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

1 reference

12 December 2020

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

1 reference

12 December 2020

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

1 reference

12 December 2020

Biochemical analysis of the damage recognition process in nucleotide excision repair

1 reference

12 December 2020

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

12 December 2020

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

1 reference

12 December 2020

The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk

1 reference

12 December 2020

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

1 reference

12 December 2020

Excision repair cross complementing-group 1: gene expression and platinum resistance.

1 reference

12 December 2020

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

1 reference

12 December 2020

Identification of single nucleotide polymorphisms in human DNA repair genes

1 reference

12 December 2020

Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients

1 reference

12 December 2020

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

10.1007/S11605-009-0881-Z

Identifiers

DOI

1 reference

24 November 2017

1 reference